テネコ （Tenneco） は、ジャパンモビリティショーで最新のライドソリューション、クリーンエア、システム保護テクノロジーを紹介
26 oct. 2023 04h00 HE
|
Tenneco
同社の先進的な電子制御およびパッシブダンパーは、OEM企業による優れたドライビング体験の提供を支援革新的なコールドスタートサーマルユニット技術により、欧州委員会が提案する排ガス規制「ユーロ７（Euro 7）」への極めて効果的でコスト効率の高い道を示す最先端の保護ソリューションにより、EVおよび ICE用途での安全性・信頼性を強化 イリノイ州ノースビル, Oct. 26, 2023 ...
BCNN TEKUMO ANNOUNCES Q3 PRELIMINARY RESULTS
18 oct. 2023 09h30 HE
|
Balincan USA, Inc.
NEW YORK, Oct. 18, 2023 (GLOBE NEWSWIRE) -- Balincan USA Inc. ("Balincan" or the "Company") and Tekumo announces preliminary results for the third quarter. Revenue for the third quarter...
Anaqua Builds on its Momentum in Japan with New Leadership, Clients, Solutions and Country HQ
26 sept. 2023 03h00 HE
|
Anaqua
BOSTON, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Anaqua, the leading global innovation and intellectual property (IP) management technology provider, today announced changes to its executive leadership...
The Human Rights and Rights to Religious Freedom of 600,000 Japanese Citizens are at Risk
21 sept. 2023 20h02 HE
|
Center for Studies on New Religions, "Bitter Winter"
Washington, DC, Sept. 21, 2023 (GLOBE NEWSWIRE) -- FOR IMMEDIATE RELEASE Center for Studies on New Religions, Human Rights and Religious Freedom Experts Decry Government Persecution of...
Inventiva et Hepalys Pharma, Inc., signent un accord de licence exclusif pour développer et commercialiser lanifibranor au Japon et en Corée du Sud
20 sept. 2023 16h00 HE
|
INVENTIVA
Hepalys Pharma, Inc. est une nouvelle société créée par Catalys Pacific, et dans laquelle Inventiva détient une participation de 30%. Dans le cadre de l’accord de licence exclusif, Inventiva...
Inventiva and Hepalys Pharma, Inc. announce exclusive licensing agreement to develop and commercialize lanifibranor in Japan and South Korea
20 sept. 2023 16h00 HE
|
INVENTIVA
Hepalys Pharma, Inc. is a new company created by Catalys Pacific and in which Inventiva has a 30% ownership position. Under the exclusive licensing agreement, Inventiva will receive a $10 million...
The Human Rights and Rights to Religious Freedom of 600,000 Japanese Citizens are at Risk
19 sept. 2023 22h04 HE
|
Center for Studies on New Religions, "Bitter Winter"
Washington, DC, Sept. 19, 2023 (GLOBE NEWSWIRE) -- FOR IMMEDIATE RELEASE Center for Studies on New Religions, Human Rights and Religious Freedom Experts Decry Government Persecution of...
The Human Rights and Rights to Religious Freedom of 600,000 Japanese Citizens are at Risk
19 sept. 2023 14h07 HE
|
Center for Studies on New Religions, "Bitter Winter"
Washington, DC, Sept. 19, 2023 (GLOBE NEWSWIRE) -- FOR IMMEDIATE RELEASE Center for Studies on New Religions, Human Rights and Religious Freedom Experts Decry Government Persecution of...
ClimateAi Announces Expanded Presence in Japan to Advance Climate Resilience Solutions
14 sept. 2023 07h00 HE
|
ClimateAi
SAN FRANCISCO, Sept. 14, 2023 (GLOBE NEWSWIRE) -- ClimateAi, one of the fastest-growing climate resilience software service providers, today announced the expansion of its presence in Japan with a...
サリプロ・バイオテック (Salipro Biotech)、住友ファーマと研究提携を締結し、創薬プログラムを推進
12 sept. 2023 02h00 HE
|
Salipro Biotech AB
本提携では、サリプロ・バイオテックの独自の専門知識とSalipro®プラットフォーム技術を活用して困難な薬物標的を安定化し、住友ファーマの創薬プログラムによる化合物の薬理学的特性を研究 する。 スウェーデン・ストックホルム発, Sept. 12, 2023 (GLOBE NEWSWIRE) -- スウェーデンのバイオテクノロジー企業であるサリプロ・バイオテックAB (Salipro...